Maggie Yuen is a seasoned financial executive with extensive experience in senior leadership roles across various organizations. Currently serving as Chief Financial Officer at Penumbra, Inc. since December 2019, Yuen also holds a board member position at AtriCure, Inc. since June 2021. Previous roles include Vice President of Finance for Thermo Fisher Scientific's Genetic Science Division from March 2016 to December 2019, and CFO at Mirion Technologies, Inc. from November 2012 to January 2016. Yuen's career began in financial analysis positions, progressing through roles such as Finance Director and Controller at Boston Scientific, and Director of Financial Planning & Analysis at Glu Mobile. Educational credentials include a Bachelor of Applied Science in Accounting and an MBA from Case Western Reserve University.